3 Best Stocks to Buy Today, According to Top Wall Street Analysts – Sept. 29
According to Top Wall Street Analysts, the three stocks below are Strong Buys. Each recently received a new Buy rating and offers significant ...
Cervomed Inc. (CRVO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Woodline Partners Michael Rockefeller And Karl Kroeker | 688,987 | $2,135,859 | 0.01% | |
| 2. | Sabby Capital Hal Mintz | 248,880 | $771,528 | 0.7% | |
| 3. | Millennium Management Israel Englander | 0 | $0 | 0% | |
| 4. | Renaissance Technologies Jim Simons | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.14 | 955,414 | $2,999,999.96 | 1,795,865 | 2026-06-11 | Filing | |
| $7.95 | 1,500 | $11,925.00 | 15,000 | 2025-11-18 | Filing | |
| $8.43 | 3,500 | $29,505.00 | 13,500 | 2025-11-17 | Filing | |
| $8.46 | 10,807 | $91,427.22 | 12,500 | 2025-11-17 | Filing | |
| $8.46 | 10,793 | $91,308.78 | 1,484,078 | 2025-11-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 36 | $0.00 | 840,451 | 2024-02-26 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 50,050 | $146,647 | 0.08% | |
| 2. | 11,500 | $34,155 | 0% | |
| 3. | 145 | $431 | 0% |
News See All
CervoMed (CRVO)’s Q4 Results Feature Advancements in Its Neflamapimod Program for Dementia Lewy Bodies (DLB)
CervoMed Inc. (NASDAQ:CRVO) earns a place on our top 10 stocks under $5 that could triple. On March 17, 2026, CervoMed Inc. (NASDAQ:CRVO) announced results for the fourth quarter and full year 2025.
Top 10 Stocks Under $5 That Could Triple
In this piece, we discuss the Top 10 Stocks Under $5 That Could Triple.
CervoMed Strengthens Leadership with Technical Operations Hire to Advance Neflamapimod Toward Phase 3
CervoMed Inc. (NASDAQ:CRVO) is one of the best-performing NASDAQ stocks according to analysts. On June 10, CervoMed announced a significant addition to its senior leadership team. Dr.
12 Best Performing NASDAQ Stocks According to Analysts
On July 3, Dan Ives, the Global Head of Tech Research at Wedbush, appeared on CNBC to suggest that AI will fuel a multi-year tech rally.
10 Best Short Squeeze Stocks to Buy According to Analysts
This article will look into the 10 best short-squeeze stocks that have gained analysts' attention. Stock market trading has an ever-changing environment.
10 Best Short-Term Stocks To Buy Right Now
This article will look into the 10 best short-term stocks with a buying opportunity for investors.
Why CervoMed (CRVO) Is Advancing Today
CervoMed (CRVO) is climbing 3% after Boral Capital upgraded the shares to Buy from Hold. The investment bank placed a $10 price target on the drug maker.